Back to search
Sickle Red Blood Cell
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sickle Red Blood Cell trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Sickle Red Blood Cell trials you may qualify forThe aim of this study to evaluate the safety and efficacy of a nonmyeloablative conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSC…
A phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or w…
To determine the feasibility and efficacy of matching donor red cells by RH genotype for a cohort of chronically transfused patients with SCD.
Background: Some people with the same disorder on a genetic level have more complications than others. Researchers want to look for a link between the PKLR gen…
A single center, open label, interventional, phase II trial for donor transplant for high risk hemoglobinopathies and other red cell transfusion dependent disor…
This study will collect representative blood samples from healthy children and adults and from children and adults who have unique red blood cell features that…
Background: Sickle cell disease (SCD) is a disorder that causes episodes of acute pain and progressive organ damage. Ways to manage SCD have evolved slowly. Tr…
The purpose of this study is to compare the efficacy and safety of 2 doses of crizanlizumab (5.0 mg/kg and 7.5 mg/kg) versus placebo in adolescent and adult sic…